NPASS Compound

Natural Product: NPC506797

Natural Product ID	NPC506797
Common Name ? The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.	(3~{S},10~{R},13~{R},17~{R})-17-[(1~{R})-2-[(1~{R})-2-isopropyl-1,3-dimethyl-cycloprop-2-en-1-yl]-1-methyl-ethyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1~{H}-cyclopenta[a]phenanthren-3-ol
IUPAC Name	(3~{S},10~{R},13~{R},17~{R})-17-[(1~{R})-2-[(1~{R})-2-isopropyl-1,3-dimethyl-cycloprop-2-en-1-yl]-1-methyl-ethyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1~{H}-cyclopenta[a]phenanthren-3-ol
Synonyms
Synthetic Gene Cluster	n.a.
ChEMBL Identifier	n.a.
PubChem CID	n.a.
Chemical Classification	CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

Chemical Representations

RDKit 3D 79 83 0 0 0 0 0 0 0 0999 V2000 -5.4741 2.1677 0.2010 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.1502 0.7480 -0.0921 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0745 -0.5811 0.2122 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.3689 -1.5231 1.3119 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.4881 -2.4807 0.8646 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.9617 -0.8225 2.5426 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.6175 -0.2391 -1.1135 C 0 0 1 0 0 0 0 0 0 0 0 0 -5.6259 -0.3917 -2.2711 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2310 0.1222 -1.5213 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1982 0.1314 -0.4487 C 0 0 1 0 0 0 0 0 0 0 0 0 -2.1453 -1.3097 0.0820 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8470 0.4120 -1.0739 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.8994 1.7662 -1.8133 C 0 0 0 0 0 0 0 0 0 0 0 0 0.5820 1.9743 -2.0864 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1618 1.6547 -0.7490 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5801 1.1565 -0.8225 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8186 0.1215 -1.8642 C 0 0 0 0 0 0 0 0 0 0 0 0 3.6819 -1.0011 -1.3835 C 0 0 0 0 0 0 0 0 0 0 0 0 4.4521 -0.9425 -0.3273 C 0 0 0 0 0 0 0 0 0 0 0 0 5.3024 -2.0652 0.1360 C 0 0 0 0 0 0 0 0 0 0 0 0 6.5882 -1.5167 0.6804 C 0 0 1 0 0 0 0 0 0 0 0 0 7.3492 -1.0370 -0.3961 O 0 0 0 0 0 0 0 0 0 0 0 0 6.4120 -0.4846 1.7449 C 0 0 0 0 0 0 0 0 0 0 0 0 5.0315 0.0837 1.8346 C 0 0 0 0 0 0 0 0 0 0 0 0 4.4792 0.3194 0.4555 C 0 0 1 0 0 0 0 0 0 0 0 0 5.2664 1.4036 -0.2237 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0243 0.7897 0.5556 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1456 -0.2078 1.2257 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8625 -0.5119 0.4630 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2074 0.7197 -0.0559 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.4106 1.4146 1.1705 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.9843 2.5811 -0.6797 H 0 0 0 0 0 0 0 0 0 0 0 0 -6.1853 2.1990 1.0516 H 0 0 0 0 0 0 0 0 0 0 0 0 -4.5553 2.7542 0.4850 H 0 0 0 0 0 0 0 0 0 0 0 0 -4.4763 -2.0923 1.5842 H 0 0 0 0 0 0 0 0 0 0 0 0 -6.0532 -3.4104 0.4333 H 0 0 0 0 0 0 0 0 0 0 0 0 -7.1809 -1.9750 0.1600 H 0 0 0 0 0 0 0 0 0 0 0 0 -7.1026 -2.7991 1.7350 H 0 0 0 0 0 0 0 0 0 0 0 0 -5.1624 -0.5728 3.2711 H 0 0 0 0 0 0 0 0 0 0 0 0 -6.7024 -1.4713 3.0535 H 0 0 0 0 0 0 0 0 0 0 0 0 -6.5086 0.0626 2.1694 H 0 0 0 0 0 0 0 0 0 0 0 0 -6.3324 -1.1986 -2.0791 H 0 0 0 0 0 0 0 0 0 0 0 0 -6.0914 0.5882 -2.4883 H 0 0 0 0 0 0 0 0 0 0 0 0 -5.0399 -0.6782 -3.1885 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.1943 1.1480 -2.0001 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.9027 -0.5928 -2.3095 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.4216 0.7717 0.4026 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.1513 -1.3686 1.1678 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.2610 -1.8542 -0.3334 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.0423 -1.8952 -0.2815 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.5534 -0.3768 -1.7468 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.2467 2.5532 -1.1444 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.4429 1.6823 -2.7774 H 0 0 0 0 0 0 0 0 0 0 0 0 0.8683 1.3074 -2.8980 H 0 0 0 0 0 0 0 0 0 0 0 0 0.7888 3.0120 -2.4214 H 0 0 0 0 0 0 0 0 0 0 0 0 1.1951 2.6069 -0.1691 H 0 0 0 0 0 0 0 0 0 0 0 0 3.1951 2.0591 -1.1176 H 0 0 0 0 0 0 0 0 0 0 0 0 1.9007 -0.3390 -2.2813 H 0 0 0 0 0 0 0 0 0 0 0 0 3.3604 0.5336 -2.7663 H 0 0 0 0 0 0 0 0 0 0 0 0 3.6724 -1.9358 -1.9494 H 0 0 0 0 0 0 0 0 0 0 0 0 5.5621 -2.7610 -0.6880 H 0 0 0 0 0 0 0 0 0 0 0 0 4.8250 -2.6639 0.9376 H 0 0 0 0 0 0 0 0 0 0 0 0 7.1892 -2.3679 1.1024 H 0 0 0 0 0 0 0 0 0 0 0 0 7.5543 -1.7678 -1.0091 H 0 0 0 0 0 0 0 0 0 0 0 0 7.1498 0.3608 1.6523 H 0 0 0 0 0 0 0 0 0 0 0 0 6.6437 -0.9287 2.7573 H 0 0 0 0 0 0 0 0 0 0 0 0 4.3321 -0.5323 2.4387 H 0 0 0 0 0 0 0 0 0 0 0 0 5.1098 1.0876 2.3252 H 0 0 0 0 0 0 0 0 0 0 0 0 6.3289 1.4590 0.1419 H 0 0 0 0 0 0 0 0 0 0 0 0 5.2750 1.2384 -1.3180 H 0 0 0 0 0 0 0 0 0 0 0 0 4.8380 2.4104 0.0389 H 0 0 0 0 0 0 0 0 0 0 0 0 3.0875 1.7551 1.1396 H 0 0 0 0 0 0 0 0 0 0 0 0 1.8739 0.1932 2.2259 H 0 0 0 0 0 0 0 0 0 0 0 0 2.6446 -1.1781 1.4095 H 0 0 0 0 0 0 0 0 0 0 0 0 0.1908 -0.9446 1.2526 H 0 0 0 0 0 0 0 0 0 0 0 0 1.0223 -1.3186 -0.2781 H 0 0 0 0 0 0 0 0 0 0 0 0 0.4665 1.8115 1.7415 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.0179 2.2847 0.8717 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.9179 0.6927 1.8126 H 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 2 0 3 4 1 0 4 5 1 0 4 6 1 0 3 7 1 0 7 8 1 6 7 9 1 0 9 10 1 0 10 11 1 0 10 12 1 0 12 13 1 0 13 14 1 0 14 15 1 0 15 16 1 0 16 17 1 0 17 18 1 0 18 19 2 0 19 20 1 0 20 21 1 0 21 22 1 0 21 23 1 0 23 24 1 0 24 25 1 0 25 26 1 6 25 27 1 0 27 28 1 0 28 29 1 0 29 30 1 0 30 31 1 1 7 2 1 0 30 12 1 0 30 15 1 0 27 16 1 0 25 19 1 0 1 32 1 0 1 33 1 0 1 34 1 0 4 35 1 0 5 36 1 0 5 37 1 0 5 38 1 0 6 39 1 0 6 40 1 0 6 41 1 0 8 42 1 0 8 43 1 0 8 44 1 0 9 45 1 0 9 46 1 0 10 47 1 1 11 48 1 0 11 49 1 0 11 50 1 0 12 51 1 6 13 52 1 0 13 53 1 0 14 54 1 0 14 55 1 0 15 56 1 0 16 57 1 0 17 58 1 0 17 59 1 0 18 60 1 0 20 61 1 0 20 62 1 0 21 63 1 1 22 64 1 0 23 65 1 0 23 66 1 0 24 67 1 0 24 68 1 0 26 69 1 0 26 70 1 0 26 71 1 0 27 72 1 0 28 73 1 0 28 74 1 0 29 75 1 0 29 76 1 0 31 77 1 0 31 78 1 0 31 79 1 0 M END

Standard InCHIKey	XWJYKMIJDLSPOV-QLWFVXFQSA-N
Standard InCHI	InChI=1S/C30H48O/c1-18(2)27-20(4)30(27,7)17-19(3)24-10-11-25-23-9-8-21-16-22(31)12-14-28(21,5)26(23)13-15-29(24,25)6/h8,18-19,22-26,31H,9-17H2,1-7H3/t19-,22+,23?,24-,25?,26?,28+,29-,30-/m1/s1
SMILES	CC1=C(C(C)C)[C@]1(C)C[C@@H](C)[C@H]1CCC2C3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@@]21C

Calculated Properties

Physi-Chem Properties

Molecular Weight:	424.37	Volume:	488.171 ? Van der Waals volume.
Dense:	0.869	LogP:	6.118 ? The logarithm of the n-octanol/water distribution coefficients.
logD7.4:	4.579 ? The logarithm of the n-octanol/water distribution coefficient at pH=7.4.	LogS:	-6.07 ? The logarithm of aqueous solubility value.
Rotatable Bonds:	4.0	Rigid Bonds:	23.0
TPSA:	20.23 ? Topological Polar Surface Area.	H-Bond Acceptor:	1.0
H-Bond Donor:	1.0	Rings:	5.0
Heavy Atoms:	1.0

MedChem Properties

QED Drug-Likeness Score:	0.454	GASA:	1.0 ? GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:	4.81	Fsp³:	0.867
MCE-18:	87.429 ? MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.	Lipinski Rule-of-5:	Rejected
Pfizer Rule:	Accepted	GSK Rule:	Accepted
Golden Triangle Rule:	Rejected	BMS Rule:	0
Chelating Alert:	0	PAINS Alert:	0
Colloidal aggregators:	0.978	Fluc inhibitor:	0.0 ? The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:	0.119 ? The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1	Green fluorescence:	0.0 ? The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:	0.409	Promiscuous compounds:	0.025

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:	-4.826	MDCK Permeability:	-4.81
Pgp-inhibitor:	0.982	Pgp-substrate:	0.01
PAMPA:	0.006 ? The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).	Human Intestinal Absorption (HIA):	0.0
20% Bioavailability (F20%):	0.324	30% Bioavailability (F30%):	0.462
50% Bioavailability (F50%):	0.996

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):	0.576	MRP1:	0.993
Plasma Protein Binding (PPB):	96.081%	Volume Distribution (VD):	0.164
Fu:	4.928% ? The fraction unbound in plasms.	OATP1B1 inhibitor:	1.0
OATP1B3 inhibitor:	0.992	BCRP inhibitor:	0.386
BSEP inhibitor:	0.999

ADMET: Metabolism

CYP1A2-inhibitor:	0.0	CYP1A2-substrate:	0.001
CYP2C19-inhibitor:	0.066	CYP2C19-substrate:	0.153
CYP2C9-inhibitor:	0.0	CYP2C9-substrate:	0.038
CYP2D6-inhibitor:	0.0	CYP2D6-substrate:	0.015
CYP3A4-inhibitor:	0.928	CYP3A4-substrate:	0.995
CYP2B6-substrate:	0.0	CYP2C8-inhibitor:	0.979
HLM stability:	0.637 ? Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):

13.091

Half-life (T1/2):

0.545

ADMET: Toxicity

hERG Blockers:	0.221	hERG Blockers (10um):	0.462
Human Hepatotoxicity (H-HT):	0.672	Drug-induced Liver Injury (DILI):	0.311
AMES Toxicity:	0.183	Rat Oral Acute Toxicity:	0.246
Maximum Recommended Daily Dose:	0.843	Skin Sensitization:	0.81
Carcinogencity:	0.839	Eye Corrosion:	0.011
Eye Irritation:	0.194	Respiratory Toxicity:	0.688
Drug-induced Neurotoxicity:	0.347	Ototoxicity:	0.63
Hematotoxicity:	0.092	Drug-induced Nephrotoxicity:	0.414
Genotoxicity:	0.024	RPMI-8226 Immunitoxicity:	0.075
A549 Cytotoxicity:	0.493	Hek293 Cytotoxicity:	0.76
BCF:	3.037 ? Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].	IGC50:	4.917 ? 48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:	5.523 ? 48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].	LC50FM:	5.721 ? 96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

Species Source

Organism ID	Organism Name	Taxonomy Level	Family	SuperKingdom	Isolation Part	Collection Location	Collection Time	Reference
NPO24927	Calyx podatypa	Species	Phloeodictyidae	Eukaryota	n.a.	n.a.	n.a.	PMID[10843583]
NPO24927	Calyx podatypa	Species	Phloeodictyidae	Eukaryota	n.a.	n.a.	n.a.	PMID[1791477]
NPO24927	Calyx podatypa	Species	Phloeodictyidae	Eukaryota	n.a.	n.a.	n.a.	Database[COCONUT]
NPO24927	Calyx podatypa	Species	Phloeodictyidae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

NP Quantity Composition/Concentration

Organism ID	Organism Name	Organism Material Preparation	Organism Part	NP Quantity (Standard)	NP Quantity (Minimum)	NP Quantity (Maximum)	Quantity Unit	Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

Biological Activity

Molecular-level activity

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference

In vitro activity

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference

In vivo activity

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference

Experimental ADME

Experiment Model	Experiment Tissue	ADME Type	ADME Relation	ADME Value	ADME Unit	Reference

Experimental Toxicity

Quantitative toxicity

Experiment Model	Experiment Organism	Toxicity Type	Toxicity Relation	Toxicity Value	Toxicity Unit	Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity	Carcinogenicity	Mutagenicity	Cardiotoxicity	Respiratory Toxicity	Eye Irritation	Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
☉ ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
☉ TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]

Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

● The left chart: Distribution of similarity level between NPC506797 and all remaining natural products in the NPASS database.
● The right table: Most similar natural products (Tc>=0.5 or Top200).

range	Tanimoto Coefficient
0-0.1	24936
0.1-0.2	21164
0.2-0.3	3410
0.3-0.4	215
0.4-0.5	76
0.5-0.6	19
0.6-0.7	22
0.7-0.8	2
0.8-0.85	0
0.85-0.9	0
0.9-0.95	0
0.95-1	0

Similarity Score	Similarity Level	Natural Product ID
0.7843	Intermediate Similarity	NPC162742
0.7843	Intermediate Similarity	NPC304309
0.7843	Intermediate Similarity	NPC470228
0.7692	Intermediate Similarity	NPC34019
0.7407	Intermediate Similarity	NPC230301
0.7407	Intermediate Similarity	NPC198968
0.7407	Intermediate Similarity	NPC285893
0.7407	Intermediate Similarity	NPC134847
0.7358	Intermediate Similarity	NPC22105
0.7358	Intermediate Similarity	NPC107059
0.7222	Intermediate Similarity	NPC136188
0.7222	Intermediate Similarity	NPC28657
0.7222	Intermediate Similarity	NPC474216
0.7018	Intermediate Similarity	NPC472265
0.6964	Remote Similarity	NPC241290
0.6964	Remote Similarity	NPC164840
0.6964	Remote Similarity	NPC484739
0.6964	Remote Similarity	NPC209944
0.6964	Remote Similarity	NPC264245
0.6964	Remote Similarity	NPC155986
0.6909	Remote Similarity	NPC154330
0.6842	Remote Similarity	NPC321381
0.6786	Remote Similarity	NPC113733
0.678	Remote Similarity	NPC155011
0.6727	Remote Similarity	NPC221758
0.6727	Remote Similarity	NPC600590
0.6724	Remote Similarity	NPC59453
0.6667	Remote Similarity	NPC51014
0.661	Remote Similarity	NPC603646
0.65	Remote Similarity	NPC473943
0.6441	Remote Similarity	NPC33913
0.6393	Remote Similarity	NPC47761
0.6393	Remote Similarity	NPC488870
0.6066	Remote Similarity	NPC477522
0.6034	Remote Similarity	NPC328313
0.6	Remote Similarity	NPC328714
0.5968	Remote Similarity	NPC243985
0.5968	Remote Similarity	NPC280710
0.5968	Remote Similarity	NPC240650
0.5902	Remote Similarity	NPC318495
0.5873	Remote Similarity	NPC474164
0.5818	Remote Similarity	NPC96319
0.5738	Remote Similarity	NPC87604
0.5606	Remote Similarity	NPC601043
0.5606	Remote Similarity	NPC605412
0.541	Remote Similarity	NPC76879
0.5397	Remote Similarity	NPC1272
0.5397	Remote Similarity	NPC470614
0.5333	Remote Similarity	NPC151519
0.5246	Remote Similarity	NPC20688
0.5224	Remote Similarity	NPC474349
0.5224	Remote Similarity	NPC474189
0.5167	Remote Similarity	NPC81306
0.5077	Remote Similarity	NPC474752
0.5077	Remote Similarity	NPC474683

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

● The left chart: Distribution of similarity level between NPC506797 and all drugs/candidates.
● The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

range	Tanimoto Coefficient
0-0.1	7662
0.1-0.2	1309
0.2-0.3	148
0.3-0.4	23
0.4-0.5	3
0.5-0.6	2
0.6-0.7	1
0.7-0.8	2
0.8-0.85	0
0.85-0.9	0
0.9-0.95	0
0.95-1	0

Similarity Score	Similarity Level	Drug ID	Developmental Stage
0.7407	Intermediate Similarity	NPD7339	Approved
0.7222	Intermediate Similarity	NPD6942	Phase 4
0.6727	Remote Similarity	NPD4786	Phase 1
0.5818	Remote Similarity	NPD3701	Pre-clinical
0.5333	Remote Similarity	NPD3667	Phase 4

Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity

B: biological targets similarity

C: networks similarity

D: cell-based bioactivity similarity

E: similarity based on clinical data